Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
29054 | 158 | 34.5 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2295 | 4123 | CANCER CACHEXIA//CACHEXIA//PROTEOLYSIS INDUCING FACTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MORPH ANAL GRP | Address | 8 | 70% | 4% | 7 |
2 | CORE MUSCLE SIZE | Author keyword | 1 | 100% | 1% | 2 |
3 | INTRAMUSCULAR ADIPOSE TISSUE CONTENT | Author keyword | 1 | 100% | 1% | 2 |
4 | SKELETAL MUSCLE DENSITY | Author keyword | 1 | 100% | 1% | 2 |
5 | SKELETAL MUSCLE DEPLETION | Author keyword | 1 | 100% | 1% | 2 |
6 | ANALYTIC MORPHOMICS | Author keyword | 1 | 40% | 1% | 2 |
7 | BODY COMPOSITION ALTERATIONS | Author keyword | 1 | 50% | 1% | 1 |
8 | CARDIOVASC 5463 | Address | 1 | 50% | 1% | 1 |
9 | CERIA ANGIOGENESIS INHIBITORS MED ON | Address | 1 | 50% | 1% | 1 |
10 | HEALTHY AGING CLIN | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CORE MUSCLE SIZE | 9 | 67% | 5% | 8 |
2 | CHEMOTHERAPY TOXICITY | 5 | 24% | 12% | 19 |
3 | ANALYTIC MORPHOMICS | 2 | 43% | 2% | 3 |
4 | COMPOSITION PARAMETERS | 1 | 50% | 1% | 2 |
5 | MUSCLE DEPLETION | 1 | 100% | 1% | 2 |
6 | EPIRUBICIN PHARMACOKINETICS | 1 | 50% | 1% | 1 |
7 | SKELETAL MUSCLE STRENGTH | 1 | 11% | 3% | 5 |
8 | RESEARCH ENGINEERING NETWORK | 0 | 33% | 1% | 1 |
9 | SEVERE MUSCLE DEPLETION | 0 | 33% | 1% | 1 |
10 | PREHABILITATION | 0 | 13% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: A systematic review | 2015 | 2 | 46 | 22% |
Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer | 2013 | 11 | 30 | 70% |
Body composition in chemotherapy: the promising role of CT scans | 2013 | 3 | 19 | 68% |
Core muscle size assessed by perioperative abdominal CT scan is related to mortality, postoperative complications, and hospitalization after major abdominal surgery: a systematic review | 2014 | 4 | 44 | 34% |
Clinical outcomes related to muscle mass in humans with cancer and catabolic illnesses | 2013 | 7 | 55 | 40% |
Muscle wasting: a nutritional criterion to prioritize patients for liver transplantation | 2014 | 4 | 26 | 27% |
Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review | 2015 | 0 | 30 | 33% |
Sarcopenia: Current Concepts and Imaging Implications | 2015 | 0 | 102 | 27% |
Importance of Lean Body Mass in the Oncologic Patient | 2012 | 15 | 44 | 18% |
Clinical implications of body composition assessment by computed tomography in metastatic renal cell carcinoma | 2014 | 0 | 53 | 26% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MORPH ANAL GRP | 8 | 70% | 4.4% | 7 |
2 | CARDIOVASC 5463 | 1 | 50% | 0.6% | 1 |
3 | CERIA ANGIOGENESIS INHIBITORS MED ON | 1 | 50% | 0.6% | 1 |
4 | HEALTHY AGING CLIN | 1 | 50% | 0.6% | 1 |
5 | QUANTIF TEAM | 1 | 50% | 0.6% | 1 |
6 | UPPER GASTROINTESTINAL GEN SURG | 1 | 50% | 0.6% | 1 |
7 | ABDOMINAL EMERGENCY SURG | 0 | 33% | 0.6% | 1 |
8 | AOUTS | 0 | 33% | 0.6% | 1 |
9 | SERV GASTROENTEROL ENDOSCOPIE DIGEST | 0 | 33% | 0.6% | 1 |
10 | TAUBMAN 2926A | 0 | 33% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000213828 | SARCOPENIA//SARCOPENIC OBESITY//PHYSICAL FUNCTION |
2 | 0.0000208177 | CANCER CACHEXIA//CACHEXIA//PROTEOLYSIS INDUCING FACTOR |
3 | 0.0000199479 | DOSE BANDING//CHEMOTHERAPY DOSING//GRANULOCYTE MACROPHAGE PROGENITOR CELLS CFU GM |
4 | 0.0000188214 | LATE EVENING SNACK//NON PROTEIN RESPIRATORY QUOTIENT//BRANCHED CHAIN AMINO ACIDS |
5 | 0.0000128301 | FRAILTY//FRAILTY INDEX//DEFICIT ACCUMULATION |
6 | 0.0000097687 | INFLAMMAT BIOL SURG SCI//ENERGY COST PER DISTANCE//IMAGING 3 DIMENSIONAL |
7 | 0.0000080480 | SERV INTEGRATO EPIDEMIOL SISTEMI INFORMAT//HLTH HLTH SERV//CARCINOMA RENAL CELL |
8 | 0.0000077721 | SIX MINUTE WALK TEST//6 MINUTE WALK TEST//WALK TEST |
9 | 0.0000076556 | PHYS EDUC RECREAT//CANCER SURVIVORS//BREAST CANCER SURVIVORS |
10 | 0.0000072179 | BIOELECTRICAL IMPEDANCE ANALYSIS//TOTAL BODY WATER//BIOELECTRICAL IMPEDANCE |